News Snapshot:
CONTACT US Chinese regulator approves first CAR-T cell therapy in the country BEIJING (Reuters) - China's National Medical Products Administration (NMPA) said on Wednesday it has approved the first CAR-T cell therapy in the coun... BEIJING (Reuters) â Chinaâs National Medical Products Administration (NMPA) said on Wednesday it has approved the first CAR-T cell therapy in the country. The drug Yescarta is approved to treat adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, NMPA said in a statement on its website. A joint venture of Shanghai Fosun Pharmaceutical Group has obtained...
